We care about: Waist and metabolic risk trends Symptoms (reflux, constipation, fatigue, sleep) Strength and function Nutrition adequacy (especially protein and hydration consistency) 3) A dose strategy built around tolerance and sustainability Clinically, we slow down escalation when symptoms persist
There are two forms of AMD, dry and wet, with wet being the more severe form
The SURMOUNT-1 data shows stronger average weight loss than the STEP trials for semaglutide, particularly at higher doses
Semaglutide increases the amount of insulin produced by your body, which then reduces the level of sugar in the blood
Weight loss is not usually sustained over time after you stop taking them
Even for non-diabetic users, improved insulin sensitivity means better nutrient partitioning, reduced fat storage, and more stable energy throughout the day